| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.39 | 2e-11 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.31 | 5e-08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.27 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |